Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter
Diagnostics Microscopy and imaging, Oncology, Screening and monitoring

Mapping an Uncharted World

The tumor microenvironment (TME) is an area of keen interest for researchers, but there is still much to learn about its multicellular structure if we are to uncover pathways to new therapeutic targets. Understanding the TME is a lot like understanding any environment – ecosystems are complex, vastly interconnected networks we must examine in granular detail to fully understand how they work.

To this end, a team of researchers extensively mapped TME structures in breast tumors from 693 patients in a bid to learn more about their characteristic heterogeneity (1). The study used imaging mass cytometry and multitiered spatial analysis to identify how the specialized cells in the breast TME organize into various structures. From there, the researchers were able to see how the clusters presented across tumors and, ultimately, how they might impact patient outcomes.

Ten recurring structures were identified in the data, varying by their vascular content, stromal quiescence versus activation, and leukocyte composition. Enrichment patterns were distinctly associated with a range of somatic alterations and differed between genomic breast cancer subtypes. The researchers also found that tissue interfaces and cancer cell-intrinsic factors impact the formation of TME structures, which then exert pressure on cancer cells. Because of the cyclical relationship between structure and function, these multicellular structures may offer valuable insight into the functional state of the TME.

Digging a little deeper, the team also found that large structures, which co-occurred with regulatory and dysfunctional T cells, could predict poor outcomes in estrogen receptor-positive breast cancer – suggesting that TME organization could one day be useful for patient stratification. This type of research will play an important role in identifying new therapeutic targets, facilitated by a more developed understanding of tumoral structural immunity. Now equipped with a map of a previously uncharted world, the researchers hope to develop new ways of identifying treatment-responsive patients.

Receive content, products, events as well as relevant industry updates from The Pathologist and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. E Danenberg et al., Nat Genet, 54, 660 (2022). PMID: 35437329.
About the Author
George Lee

Associate Editor, The Pathologist

Like most people, I didn’t know exactly what I wanted to do after university. But one thing was certain – writing would play a central role. Not one to walk the path most traveled, I decided to spend my next few years freelancing to hone my skills as a writer and further cement my love for language. Reaching people through writing is important to me and I look forward to connecting with thousands of people through Texere’s passionate audience.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register